Home Tags 2021 AACR-NCI-EORTC

Tag: 2021 AACR-NCI-EORTC

Novel Linker-Drug Technology Enables Antibody-Drug Conjugates with an Expanded Therapeutic Window

Preclinical data from a novel, proprietary ADC technology platform being developed by ProfoundBio was being presented at the 2021 Molecular Targets and Cancer Therapeutics...

X